Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 04/27

Trade details

Type
Insider sale
Amount
$1,820,459.2
Shares · price
3,220 sh · $565.36 a share
Held after
42,483 sh
Trade date
26/04/24
Filed
26/04/27
Days to filing
3 days

Sold 7.0% of holdings

Share of holding sold
7.0%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 03/25~05/24

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $775.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $537.5K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $501.3K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $477.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $446.5K

    Filed 10/02

Martine A. Rothblatt, Chairman — sold $1.8M of United Therapeutics UTHR · 7.0% of holdings · 10b5-1 plan | Whalegun